Latest press releases
March 31, 2020CELLINK AB (publ) receives an order of SEK 5,200,000 from the National Board of Health and Welfare in Sweden
March 25, 2020CELLINK launches a real-time qPCR instrument
March 22, 2020RegulatoryUpdate regarding COVID-19
March 4, 2020CELLINK has received a grant to develop a new organ-like in vitro model that can be used in drug development and testing for renal diseases.
February 3, 2020CELLINK announces extension of collaboration with AstraZeneca to use CELLINKs’ 3D-bioprinting and associated technology for drug discovery
January 29, 2020RegulatoryCELLINK has completed a directed share issue of SEK 377 million
January 29, 2020RegulatoryCELLINK announces intention to carry out a directed share issue of approximately 3,850,000 shares
January 20, 2020RegulatoryQ1 19/20: Strong sales growth and successful integration of acquisitions
January 9, 2020CELLINK is carrying out stock split (4:1)
December 23, 2019CELLINK signs agreement to expand its production area
December 18, 2019RegulatoryBulletin from the Annual General Meeting in CELLINK AB (publ)
December 13, 2019RegulatoryCELLINK’s board has set financial targets for the company
November 18, 2019RegulatoryNotice of annual general meeting of CELLINK AB (publ)
November 14, 2019Annual Report 2018/2019
November 4, 2019Bioprinting advanced skin architecture complete with blood vessels using CELLINK technology
October 24, 2019RegulatoryReport on Operations 2018-2019: Strategic acquisition and strong closing of the year
October 22, 2019Karolinska Institute study shows CELLINK’s I-DOT liquid-handling system can enable genetic cancer diagnostic research
October 14, 2019CELLINK is awarded Entrepreneur of the Year in Sweden 2019
October 2, 2019CELLINK and partner Prellis Biologics awarded Merck Innovation Award for cutting-edge technology designed to empower pharmaceutical research.
October 1, 2019CELLINK granted design patent for BIO X
September 3, 2019CELLINK announces a new product designed to be the most flexible six-printhead bioprinting platform on the market.
August 26, 2019RegulatoryCommunique from the Extraordinary General Meeting of CELLINK AB (publ)
August 8, 2019RegulatoryNotice of Extraordinary General Meeting of CELLINK AB (publ)
August 5, 2019RegulatoryCELLINK has entered an agreement to acquire single-cell dispensing company cytena GmbH.
July 11, 2019RegulatoryCELLINK has been granted a patent for "Clean chamber technology for 3D Printers and Bioprinters" from the Korean Intellectual Property Office
July 11, 2019Regulatory143% profitable growth and a successful integration of acquired technology
June 18, 2019RegulatoryCELLINK has completed a directed share issue of SEK 148.5 million
June 18, 2019RegulatoryCELLINK announces intention to carry out a directed share issue of approximately 500,000 shares of series B to finance a potential acquisition
May 2, 2019CELLINK launches new tissue model kits
April 24, 2019CELLINK BIO X wins the Grand Award of Design.
April 10, 2019RegulatoryCELLINK report continued growth and improved margins in the second quarter (December 2018-February 2019)
March 22, 2019CELLINK and the Adult Stem Cell Research Center at Seoul National University announce new agreement for bioprinting research
February 19, 2019RegulatoryCELLINK has been granted a patent for "3D printer and a method for 3D printing of a construct" from the Swedish Patent office
February 4, 2019CELLINK launches new product to bring fast and sharp live-cell imaging to every incubator
January 28, 2019CELLINK with partner has been granted project funding of SEK 10 million from the EU for the FUNC project. CELLINK's share amounts to SEK 5 million
January 22, 2019RegulatoryInterim financial report 1, September – November 2018: Continued growth and improved margins
December 14, 2018RegulatoryCommunication from the Annual General Meeting on December 13, 2018
December 7, 2018RegulatoryHandelsbanken Fonder and AP4 buy shares in CELLINK from the founders